We excel in the development of Active Pharmaceutical Ingredients (APIs) that serve as the foundation for various drug product formulations. Our experienced team of scientists and researchers work to develop new and optimized synthetic processes, enhance purity, and ensure the quality of our APIs.
Scroll
View
Swipe
Play
Research & Development
Best in class
The foundation of our continuous improvement and innovation efforts, enabling us to deliver high-quality products and services.
Our core capabilities
API Development
Formulation Development
Creating effective and reliable drug product formulations is a core strength of our R&D team. We strive to create innovative formulations to allow the earliest possible supply of high quality generics to patients thereby advancing of mission of improving patient access to affordable medicines.
Our Technology Platforms / Product Focus Areas
High containment compounds (OEB Class D and E)*
Over the years Synthon has developed the expertise and invested in specialized equipment to advance generics development for highly potent compounds used in the treatment of oncology. Our R&D efforts focus among others, on developing kinase inhibitors, a class of compounds known for their ability to modulate signaling pathways involved in various diseases.
Solid Oral Dose / Immediate Release / Modified Release
We specialize in the development of solid oral dosage forms, including immediate release and modified release formulations. Our expertise lies in optimizing drug delivery profiles, ensuring efficacy, patient convenience and addressing unmet medical needs.
Injectables
Injectable formulations represent another area of our R&D. We aim to develop safe and reliable injectable solutions that meet the highest quality standards and improved patient care.
Spray Drying / Liquid Filled Hard Gel Caps
We leverage advanced techniques such as spray drying and liquid-filled hard gel capsules to enhance drug stability, solubility, and bioavailability. These technologies enable us to create alternative pharmaceutical formulations to supply to the patients.
Global presence
Our R&D Network
Czech Republic
Located in Blansko, our facility in the Czech Republic serves as a cornerstone of our research and development endeavors. Equipped with advanced equipment and staffed by a talented team, this site plays a crucial role in driving API development within our organization.
Spain
Our research and development activities extend to Barcelona, where our facility combines scientific expertise and a wide array of technologies for drug product development. This site, complete with best in class technologies, pilot and scale up facilities serves as Synthon’s core center of excellence for drug product development.
Argentina and Chile
In addition to our core COE locations, we also utilize supportive facilities located in San Lorenzo, Argentina and Santiago, Chile, to complement our global R&D network. These sites harness local expertise and contribute to our global mission of advancing generic pharmaceutical research and development.
Contact
Partner with us
At Synthon, development excellence is embedded in our culture. Through our global development network, cutting-edge technologies, and a dedicated team, we are committed to developing high-quality pharmaceutical products that improve patient outcomes.